Alzheimer's disease trials recruiting in Vermont

All Alzheimer's disease trials nationally

Cities in Vermont

Recruiting trials in Vermont

• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
  NCT07011732 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Vermont: Bennington
• A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
  NCT06937229 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Vermont: Bennington
• Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
  NCT07284472 · Phase: Phase 2, Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Vermont: Bennington